☰

Stuart Rudikoff

Affiliations: 
National Cancer Institute National Institutes of Health, Bethesda, MD, United States 
Google:
"Stuart Rudikoff"
Mean distance: (not calculated yet)
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
Michael P. Cancro collaborator National Institutes of Health
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nordan RP, Mock BA, Neckers LM, et al. (2008) The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells. Annals of the New York Academy of Sciences. 557: 200-205
Qiang Y, Chen Y, Stephens O, et al. (2006) On the Molecular Mechanism of DKK1 Inhibition of Osteoblast Differentiation in Multiple Myeloma. Blood. 108: 3429-3429
Qiang YW, Walsh K, Yao L, et al. (2005) Wnts induce migration and invasion of myeloma plasma cells. Blood. 106: 1786-93
Crowder C, Dahle Ø, Davis RE, et al. (2005) PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction. Blood. 105: 1280-7
Qiang YW, Yao L, Tosato G, et al. (2004) Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood. 103: 301-8
Qiang YW, Endo Y, Rubin JS, et al. (2003) Wnt signaling in B-cell neoplasia. Oncogene. 22: 1536-45
Ge NL, Rudikoff S. (2000) Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo Oncogene. 19: 4091-4095
Ge N, Rudikoff S. (2000) Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood. 96: 2856-2861
Swaminathan N, Lopez-Berestein G, Rudikoff S. (1999) Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia. Medical Oncology (Northwood, London, England). 16: 119-28
Kopantzev E, Roschke V, Rudikoff S. (1998) Interleukin-2-Mediated Modulation of Plasma Cell Tumor Growth in a Model of Multiple Myeloma Human Gene Therapy. 9: 13-19
See more...